Nippi,Incorporated Stock

Equities

7932

JP3685200002

Food Processing

Delayed Japan Exchange 12:05:36 2024-04-26 am EDT 5-day change 1st Jan Change
5,390 JPY 0.00% Intraday chart for Nippi,Incorporated -0.74% -9.56%
Sales 2022 39.35B 253M Sales 2023 44.81B 288M Capitalization 10.93B 70.24M
Net income 2022 1.14B 7.35M Net income 2023 1.17B 7.51M EV / Sales 2022 0.5 x
Net Debt 2022 9.43B 60.59M Net Debt 2023 7.94B 51.05M EV / Sales 2023 0.42 x
P/E ratio 2022
8.86 x
P/E ratio 2023
9.35 x
Employees 611
Yield 2022
1.7%
Yield 2023
2.11%
Free-Float 61.01%
More Fundamentals * Assessed data
Dynamic Chart
Nippi,Incorporated Reports Earnings Results for the Full Year Ended March 31, 2023 CI
The Chiba Kogyo Bank, Ltd. announced that it has received ¥32.65 billion in funding from a group of investors CI
The Chiba Kogyo Bank, Ltd. announced that it expects to receive ¥32.65 billion in funding from a group of investors CI
Nippi, Incorporated announces an Equity Buyback for 90 shares. CI
Nippi, Incorporated's Equity Buyback announced on October 25, 2017 has expired. CI
Nippi, Incorporated authorizes a Buyback Plan. CI
Matorikusomu Co., Ltd. announced that it expects to receive ¥275 million in funding from Nippi, Incorporated, SMBC Venture Capital Co., Ltd., OSAKA University Venture Capital Co., Ltd.. CI
Japan Aircraft Development Corporation, Mitsubishi Heavy Industries, Ltd., Kawasaki Heavy Industries, Ltd., Fuji Heavy Industries Ltd., ShinMaywa Industries, Ltd. and NIPPI Corporation Sign Memorandum of Agreement to Develop and Produce the Boeing 777X CI
Certain shares of Nippi, Incorporated's Common Shares are subject to a Lock-Up Agreement Ending on 22-JUN-2014. CI
Takara Bio Inc. Reaches Distribution Agreement with Nippi Inc CI
Nomura Holdings Inc, Asset Management Arm completed the acquisition of 4.52% stake in Nippi, Incorporated from Regal Corporation. CI
Nomura Holdings Inc, Asset Management Arm agreed to acquire 4.52% stake in Nippi, Incorporated from Regal Corporation for approximately ¥680 million. CI
Haseko Corp. cancelled the acquisition of 2-1 and 1-20 Senjuhashido-cho from Nippi Inc.. CI
An unknown buyer acquired real estate in Nishi Yodogawa-ku, Osaka City from Nippi, Incorporated. CI
The Chiba Kogyo Bank, Ltd. announced that it has received ¥32 billion in funding from a group of investors. CI
More news
1 day-0.74%
1 week+0.56%
Current month-5.60%
1 month-5.44%
3 months-10.47%
6 months+28.64%
Current year-9.56%
More quotes
1 week
5 120.00
Extreme 5120
5 440.00
1 month
5 120.00
Extreme 5120
5 930.00
Current year
5 120.00
Extreme 5120
6 380.00
1 year
3 600.00
Extreme 3600
6 380.00
3 years
3 355.00
Extreme 3355
6 380.00
5 years
2 390.00
Extreme 2390
6 380.00
10 years
2 390.00
Extreme 2390
6 380.00
More quotes
Managers TitleAgeSince
Director of Finance/CFO 61 86-03-31
Chairman 81 99-05-31
Director/Board Member 54 04-08-31
Members of the board TitleAgeSince
Chairman 81 99-05-31
Comptroller/Controller/Auditor 68 78-03-31
Director/Board Member 81 13-05-31
More insiders
Date Price Change Volume
24-04-26 5,390 0.00% 1 500
24-04-25 5,390 -0.74% 2,100
24-04-24 5,430 +0.93% 1,500
24-04-23 5,380 +0.94% 1,600
24-04-22 5,330 -1.84% 8,900

Delayed Quote Japan Exchange, April 25, 2024 at 02:00 am EDT

More quotes
Nippi,Incorporated is a Japan-based company mainly engaged in the manufacture and sale of collagen products, gelatin products, collagen cosmetics, leather products and health food. The Company has six business segments. The Collagen and Casing segment is engaged in the provision of edible collagen casing products for sausages. The Gelatin Related segment is engaged in the provision of gelatin and peptide products for food, pharmaceutical and industrial. The Cosmetics Related segment is engaged in the provision of collagen cosmetics and health food. The Leather Related segment is engaged in the sale of leather products for shoes and bags. The Leasing and Real Estate segment is engaged in the leasing of land, buildings and equipment. The Food and Others segment is engaged in the import and sale of food, fertilizers and others, as well as the provision of chemical products, linkers, bovine spongiform encephalopathy (BSE) test kits, cell culture substrate iMatrix -511 and others.
Calendar
More about the company